芍药苷
PI3K/AKT/mTOR通路
肝纤维化
纤维化
肝星状细胞
四氯化碳
药理学
医学
化学
癌症研究
信号转导
病理
生物化学
四氯化碳
色谱法
有机化学
高效液相色谱法
作者
Yanling Zhao,Xiao Ma,Jiabo Wang,Yun Zhu,Ruisheng Li,Jian Wang,Xuan He,Limei Shan,Ruilin Wang,Lifu Wang,Yonggang Li,Xiaohe Xiao
出处
期刊:Fitoterapia
[Elsevier BV]
日期:2014-10-15
卷期号:99: 318-327
被引量:64
标识
DOI:10.1016/j.fitote.2014.10.009
摘要
HIF-1α/mTOR signaling pathway is considered to play a crucial role in genesis and progress of tissue fibrosis. The elevation of HIF-1α and mTOR is relevant to CCl4 induced liver fibrotic rats. Paeoniflorin has been consistently shown to exhibit multiple pharmacological effects in liver disease. However, so far, no research demonstrates the relationship between paeoniflorin and HIF-1α/mTOR fibrogenesis pathway in liver fibrosis. In this study, the liver fibrosis was performed by CCl4 rats and HSC-T6 cell line. The data demonstrated that paeoniflorin treatment could attenuate liver fibrosis and inhibit the activation of HSC. Moreover, paeoniflorin significantly enhanced hepatic function by decreasing serum level of ALT, AST and ALP, and increasing level of ALB, TP. Meanwhile, ECM degradation was modulated by paeoniflorin treated rats with a remarkable reduce of α-SMA and collagen III mRNA expression. Moreover, the alleviation effect of liver fibrosis was relevant to inhibiting HIF-1α and phosphor-mTOR. Our data indicate that paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α expression partly through mTOR pathway and paeoniflorin may be a potential therapeutic agent for liver fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI